15-12G

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 001-35006

 

 

Spectrum Pharmaceuticals, Inc. 401(k) Plan

as amended and restated

 

 

Spectrum Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

 

 

2 Atlantic Ave., 6th Floor

Boston, Massachusetts 02110

+1 (617) 586-3900

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Plan Interests under the Spectrum Pharmaceuticals, Inc. 401(k) Plan and its predecessor plans

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

 

Rule 12g-4(a)(2)

 

Rule 12h-3(b)(1)(i)

 

Rule 12h-3(b)(1)(ii)

 

Rule 15d-6

 

Rule 15d-22(b)

 

Approximate number of holders of record as of the certification or notice date: None

[Signature page follows]

 

 

 


Pursuant to the requirements of the Securities Exchange Act of 1934, the Spectrum Pharmaceuticals, Inc. 401(k) Plan has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: November 22, 2022     By:   SPECTRUM PHARMACEUTICALS, INC. FIDUCIARY RETIREMENT COMMITTEE, Plan Administrator
      By:  

/s/ Keith M. McGahan

      Keith M. McGahan
      Trustee